Company: SNSE
Filing Date: 2025-04-01
Form Type: PRE 14A
Source: 0000950170-25-048533
Chunk: 54

Company: Sensei Biotherapeutics, Inc.
Filing Date: 2025-04-01
Form: PRE 14A
Chunk 54
---
 15, 2025 and thereafter in 36 equal monthly installments until February 15, 2028, generally subject to the officer’s continued service through each applicable vesting date.

The unvested shares underlying this option vest in 26 equal monthly installments until February 15, 2027, generally subject to the officer’s continued service through each applicable vesting date.

The unvested shares underlying this option vest in 14 equal monthly installments until February 15, 2026, generally subject to the officer’s continued service through each applicable vesting date.

The unvested shares underlying this option vest in 2 equal monthly installments until February 15, 2025, generally subject to the officer’s continued service through each applicable vesting date.

The unvested shares underlying this option vest in 10 equal monthly installments until October 8, 2025, generally subject to the officer’s continued service through each applicable vesting date.

The unvested shares underlying this restricted stock unit vest in 3 equal yearly installments until February 15, 2027, generally subject to the officer’s continued service through each applicable vesting date.

The unvested shares underlying this restricted stock unit vest in 2 equal yearly installments until February 15, 2026, generally subject to the officer’s continued service through each applicable vesting date.

The market value amount is calculated based on the closing price of our common stock of $0.49 per share on December 31, 2024.

Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information

We have granted stock options to our employees, including our named executive officers, in 2023 and 2024. We typically have granted new-hire stock option awards or promotion stock option awards on or soon after a new hire’s employment start date or promotion, as applicable. Additionally, we have typically granted annual refresh employee stock option awards in the first quarter of each fiscal year, which refresh grants are typically approved following our regularly scheduled meeting of the Compensation Committee in which annual refresh grants are considered. We do not otherwise maintain any written policies on the timing of awards

<div align='center'>32</div>

of stock options, stock appreciation rights, or similar instruments with option-like features. The Compensation Committee considers whether there is any material nonpublic information (“MNPI”) about the Company when determining the timing of stock option grants and does not seek to time the award